| Fine tuning subsets of CD4+ T cells by low-dosage of IL-2 and a new therapeutic strategy for autoimmune diseases Z Zhao, X Zhang, L Su, L Xu, Y Zheng, J Sun International Immunopharmacology 56, 269-276, 2018 | 28 | 2018 |
| Doubly constrained C-terminal of roc (COR) domain-derived peptides inhibit leucine-rich repeat kinase 2 (LRRK2) dimerization P Pathak, KK Alexander, LG Helton, M Kentros, TJ LeClair, X Zhang, ... ACS chemical neuroscience 14 (11), 1971-1980, 2023 | 9 | 2023 |
| LRRK2 structure-based activation mechanism and pathogenesis X Zhang, A Kortholt Biomolecules 13 (4), 612, 2023 | 8 | 2023 |
| Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase dependent mechanism BK Gilsbach, FY Ho, B Riebenbauer, X Zhang, G Guaitoli, A Kortholt, ... BioRxiv, 2023.07. 31.549909, 2023 | 4 | 2023 |
| Biophysical analysis reveals autophosphorylation as an important negative regulator of LRRK2 dimerization G Guaitoli, X Zhang, F Saitta, P Miglionico, LM Silbermann, FY Ho, ... BioRxiv, 2023.08. 11.549911, 2023 | 3 | 2023 |
| Selective binding BAFF/APRIL by the in and outside conservative region of BCMA C Zheng, X Zhang, Z Zhao, X Hao, J Wei, J Sun Protein and Peptide Letters 24 (6), 489-494, 2017 | 3 | 2017 |
| BAFF antagonists designed by computer-aided drug design inhibited the interaction of BAFF with its receptors J Sun, X Zhang, Z Zhen, X Hao The Journal of Immunology 200 (1_Supplement), 164.17-164.17, 2018 | | 2018 |
